Monday, July 23, 2018

Orthobiologics Market Gain Impetus due to the Growing Demand over 2023


The global orthobiologics market is driven by increasing sports injuries and road accidents, increased obesity rate, growing awareness among people, and surging aging population. Moreover, the opportunities witnessed in the global market include development in implant technologies and shifting demand from mechanical to biological solutions. The global market has been classified in terms of product, application, end-user and geography. Based on product, the global market is segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitute, allograft, viscosupplementation, machined bones, and stem cell therapy. Based on end user, the global market is segmented into orthopedic clinics, hospitals, and others.


Orthobiologics are substances used by orthopedic surgeons for facilitating quick healing of injuries of broken bones and injured muscles, ligaments, and tendons. These products are usually made from substances found naturally in the human body. The reasons for the increasing popularity of these products include faster healing and recovery, and less need for frequent hospital visits.


Global Orthobiologics Market Segmentation

By Product
·         Bone Morphogenetic Proteins
·         Demineralized Bone Matrix
·         Synthetic Bone Substitute
·         Allograft,
·         Viscosupplementation,
·         Machined Bones
·         Stem Cell Therapy
By Application
·         Reconstructive Surgery
·         Spinal Fusion
·         Trauma
By End User
·         Orthopedic Clinics
·         Hospitals
·         Others
By Geography
·         North America
·         Europe
·         Asia
·         Rest of the World (RoW)

The geographical segmentation of the global orthobiologics market includes North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe accounted for major share in the global market, since the regions have the highest aging population, due to increase in life expectancy and prevalence of geriatric-based diseases, such as diabetes, arthritis, and obesity. The Asia-Pacific market is expected to witness surge, due to the enormous untapped patient population, increasing medical tourism, and economical treatment cost. The developing nations, such as India and China, in the Asia-Pacific market are expected to witness significant growth.

The major companies operating in the global orthobiologics market include Exactech Inc., Medtronic plc., Stryker Corporation, Synthes Inc., Smith & Nephew Plc, Zimmer Biomet, DePuy Synthes Inc (Johnson & Johnson), Tornier Inc., and others.

About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook

Tuesday, July 17, 2018

Animal Vaccines Market Rapidly Growth by Demand in Veterinary Industry

Like humans, animals also suffer from several infectious diseases such as rabies and foot and mouth disease. Introduction of advanced veterinary medicines hold prime importance in the treatment of animal diseases. However, prevention of diseases is also essential to provide immunity against various diseases. Prevention is usually done by vaccination. Vaccination also reduces the multiple doses of antibiotics used to control established diseases and has prevented long term suffering and death from diseases.


Global animal vaccines market is primarily driven by increasing incidences of zoonotic diseases in humans. Rising prevalence of animal diseases and growing investment by government bodies are also enhancing the growth of global animal vaccines market. In addition, technological innovations and introduction of innovative vaccines, such as DNA, are recombinant vaccines, and have fueled the growth of animal vaccines market.


Europe dominates the global animal vaccines market followed by North America. Germany, France and the U.K. are some of the largest markets for animal vaccines in Europe. The U.S., followed by Canada, is the largest market for animal vaccines in North America. The key driving factor for animal vaccines market in these regions is increasing research activities on various types of animal diseases.
Asia-Pacific represents the fastest growing region in the global animal vaccines market. This is due to minimal wages and availability of skilled professionals in the region. These factors attract vaccines manufacturing companies to invest in the Asian countries. In addition, increasing awareness about animal health also boosts the growth of animal vaccines market in the region. China, Japan and India are the largest animal vaccines markets in the region.


Some of the major competitors in the market include Pfizer, Sanofi-Aventis, Bayer HealthCare, Novartis, Boehringer Ingelheim, Ceva, Heska Corporation, Bioniche Animal Health Canada Inc. and Virbac.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Market Research347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

ADME Toxicology Testing Market show Exponential Growth by 2023

ADME Toxicology Testing Market
ADME stands for absorption, distribution, metabolism and elimination of the drug and chemicals define their nature in a human body. These four methods define the impact of a specific drug or chemical to the human tissues. Toxicology testing is an important phenomenon before introducing new medicine to the market. ADME toxicology facilitated pharmaceutical manufacturing company to minimize their drug discovery time, testing complications, and to reduce the cost of drug development.


Based on the different product type, global ADME-toxicology testing market can be bifurcated as instruments, software solutions, assays systems, reagents and others. Based on the technology used in the ADME-toxicology testing the market can be bifurcated as in-vivo (implemented inside a living organism), and in-vitro (test performed in a laboratory). Further In-vitro technology is bifurcated as biochemical testing and cell testing (including liver, intestinal, kidney). In-vitro technology is expected to witness the highest growth during the forecast period attributed mainly to the growing concern over animal rights for using animals for clinical trials.

Asia Pacific is expected to be the fasted growing market of ADME-Toxicology Testing during the forecast period. The growth is mainly anticipated from the supporting government initiatives and increasing number of merger and accusation (M&A) in pharmaceutical companies and research laboratories.


Some of the major players operating in the Global ADME-Toxicology Testing Market include, Accelrys, Inc., Agilent Technologies, Inc., Caliper Life Sciences, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Thermo Fisher Scientific, Inc., Molecular Discovery Ltd., Cyprotex PLC, MultiCASE, Inc., Promega Corporation, Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., Beckman Coulter, Inc., CeeTox, Inc., Molecular Discovery Ltd.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Market Research347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Monday, July 16, 2018

North America Air Quality Monitoring (AQM) Market Growing at a CAGR of 8.5% During the Period 2016–2022.

North America Air Quality Monitoring Market

The North American AQM market valued $1.4 billion in 2015 and is expected to attain a value of $2.5 billion by 2022, growing at a CAGR of 8.5% during the period 2016–2022.

Between the two types of AQM products, indoor monitors accounted for the larger share in the North American AQM market in 2015, due to their high rate of adoption in pharmaceutical and other industries owing to the need for controlled environment. Based on the type of pollutants monitored in 2015, chemical pollutants monitoring generated the largest revenue in the AQM market, followed by physical and biological pollutants monitoring.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/north-america-air-quality-monitoring-market/report-sample

The North American AQM market accounted for the largest share in the global AQM market in 2015 mainly due to rising pollution levels in the region, growing number of patients with respiratory disorders, and increasing awareness about environmental and healthcare implications of air pollution. According to the World Health Organization (WHO), approximately 324,000 new cases of lung cancer were reported in North America in 2012 and the number is estimated to reach approximately 541,000 by 2030.

Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/north-america-air-quality-monitoring-market

NORTH AMERICAN AQM MARKET SEGMENTATION

By Product Type

·         Indoor monitors

o    Fixed indoor air quality monitors

o    Portable indoor air quality monitors

·         Outdoor monitors

o    Portable outdoor air quality monitors

o    Fixed outdoor air quality monitors

o    Dust and particulate air quality monitors

o    AQM stations


By Pollutant Type

·         Chemical

·         Physical

·         Biological


By Sampling Method

·         Continuous

·         Manual

·         Passive

·         Intermittent


By End User

·         Government agencies and academic institutes

·         Commercial and residential sectors

·         Petrochemical industry

·         Power generation plants

·         Pharmaceutical industry

·         Others


By Geography

·         U.S.

·         Canada

Technological advancements by scientists and engineers in the field of AQM are changing the way air quality is monitored. Low-cost, portable air sensors are being developed to monitor pollutants in the air, especially in roadways, rail yards, ports, and industrial areas that abide by air quality standards. However, limitations of AQM products, such as limited temporal and spatial coverage by air quality monitors hindering the complete assessment of air pollutants and their health hazards, are impeding their market growth in the region.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-air-quality-monitoring-market

Some of the key players operating in the North American AQM market are the 3M Company, General Electric, Thermo Fisher Scientific Inc., TSI Inc., Emerson Electric Co., Teledyne Technologies Inc., Cerex Monitoring Solutions LLC, PerkinElmer, Inc., and Tisch Environmental Inc.


About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)

Connect with us: LinkedIn | Twitter | Google + | Facebook

Tuesday, July 10, 2018

Uterine Fibroid Treatment Market Overview, Challenges, Opportunities, Trends and Market Analysis by 2023


Uterine Fibroid Treatment Market 
The global uterine fibroid treatment market is witnessing considerable growth due to increasing female geriatric population, increasing healthcare expenditure, increasing prevalence of obesity, launch of technologically advanced fibroid treatment products and growing popularity of minimally invasive treatments. Moreover, growing prevalence of hormonal disorders or hormonal imbalance leading to fibroid formation is supporting the growth of the market. The increasing adoption of uterine fibroid treatment across the globe, owing to increasing incidence of cancer is also driving the growth of the market.


As reported by UNDESA (United Nation Department of Economic and Social Affairs) in the year 2013, the elder population is predominantly female. As women tend to live longer than men, while older women have outnumbered older men almost everywhere in the world. It further reported that in the year 2013, globally there were 85 men per 100 women in the age group 60 years or plus; and 61 men per 100 women in the age group 80 years or plus. The elderly population is more susceptible to gynecological problems, such as abnormal uterine bleeding, hormonal imbalance, and irregular menstrual cycle as compared to adults, which is fueling the demand of the global fibroid treatment market.


Geographically, North America has been the largest market for uterine fibroid treatment, owing to its increased awareness, established healthcare industry, and easy accessibility to advanced technologies due to the presence of high number of hospitals, clinics and ambulatory surgical centers in the region. The U.S. contributed largest revenue to the North American as well as global uterine fibroid treatment market. The increased patient pool undergoing hormonal disorders and increasing prevalence of uterine cancer is the key growth driving factor for the U.S. uterine fibroid treatment market.

Europe has been the second largest market for uterine fibroid treatment, where the market is driven by the presence of a large pool of uterine cancer patients, increasing healthcare expenditure and rapidly developing healthcare infrastructure. In 2015, Germany lead the European uterine fibroid treatment market and it is also expected to grow at the fastest rate in Europe, during the forecast period. Globally, the uterine fibroid treatment market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing prevalent cases with abnormal uterine bleeding, irregular menstrual cycle, increasing per capita income leading to improved standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about uterine fibroid treatment in the region.


The key players operating in the global market are Boston Scientific Corporation, CooperSurgical, Inc., Karl Storz, Halt Medical, Inc., Merit Medical Systems, LiNA Medical USA, Olympus Corporation, and Richard Wolf GmbH.

About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:

P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook

Anti Microbial Coating for Medical Devices Market by Type of Material, Device Type, Geography and Foresight by 2023

Anti Microbial Coating for Medical Devices Market

The global anti-microbial coating for medical devices market is growing, due to increasing number of hospitals and surgical centers, increasing number of free trade agreements, and technological advancement, such as nanocomposite coating technology, novel coating technology and parylene technology. The metallic coating segment is expected to dominate the market and non-metallic segment is expected to grow at the faster rate during the forecasted period. 


Antimicrobial coating is used in medical devices to reduce the risk of infection and demolish microorganisms from medical devices. These coatings should be bio-compatible, bio-stable and non-toxic for various medical devices.

Anti-Microbial Coating for Medical Devices Market Segmentation
By Type of Material
·         Metallic Coating
o    Silver coating
o    Copper coating
o    Others metallic coating
·         Non-metallic Coating
o    Organic coating
o    Polymeric coating
By Device Type
·         Implantable Devices
·         Surgical Instruments
·         Catheters
·         Others
By Geography
·         North America
·         Europe
·         Asia-Pacific
·         Rest of the World
Geographically, North America is expected to dominate the global market of anti-microbial coating for medical devices in the coming years, due to increasing prevalence of hospital acquired infections, strict regulations on antimicrobial-coated medical devices, increasing prevalence of chronic and lifestyle associated diseases, and growing geriatric population. Asia-Pacific is expected to be the fastest growing region in the market, due to increasing number of hospitals, improving healthcare infrastructure, and increasing geriatric population in the region. In addition, the Asia-Pacific market of anti-microbial coating for medical devices is growing, due to increasing demand for high quality medical devices, increasing geriatric population, and increasing number of endoscopic surgeries in the emerging countries, such as India and China.


Some of the companies operating in the global anti-microbial coating for medical devices market are Royal DSM, PPG Industries Inc., Sciessent LLC, BASF SE, Biointeractions Ltd., Covalon Technologies Ltd., AST Products Inc., Hydromer Inc., The DOW Chemical Company, and Specialty Coating Systems Inc.